Cookies disclaimer

I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.

151-67-7 - 1-Bromo-1-chloro-2,2,2-trifluoroethane, 99% - 2-Bromo-2-chloro-1,1,1-trifluoroethane - Halothane - L10179 - Alfa Aesar

L10179 1-Bromo-1-chloro-2,2,2-trifluoroethane, 99%

CAS-Nummer
151-67-7
Synonyme
2-Bromo-2-chloro-1,1,1-trifluoroethane
Halothane

Größe Preis ($) Menge Verfügbarkeit
25g 37,29
100g 93,42
Zum Warenkorb hinzufügen Zur Angebotsanfrage hinzufügen Artikel anzeigen

1-Bromo-1-chloro-2,2,2-trifluoroethane, 99%

MDL
MFCD00009602
EINECS
205-796-5

Chemische Eigenschaften

Formel
CF3CHBrCl
Molmasse
197.39
Siedepunkt
49-50°
Dichte
1.872
Brechungsindex
1.3691
Sensitivität
Light Sensitive
Löslichkeit
Soluble in water (8 mg/ml).

Anwendungen

1-Bromo-1-chloro-2,2,2-trifluoroethane has been used in a study that combined molecular simulations with free energy simulations to study solvation of halothane in polarizable water and methanol. It is also used in a study to investigate the interaction of anesthetics with the Rho GTPase regulator Rho GDP dissociation inhibitor. In an effect believed to be independent of anesthesia, halothane inhibits synthesis of 5-hydroxytryptamine in brain tissue, probably at the tryptophan hydroxylase step.

Bemerkungen

Light Sensitive. Store in the dark. Store away from oxidizing agents. Incompatible with light and oxidizing agents.

Literaturverweise

S Bourgoin; J P Ternaux; A Boireau; F Héry; M Hamon. Effects of halothane and nitrous oxide anesthesia on 5-HT turn-over in the rat brain.Naunyn-Schmiedebergs Archives of Pharmacology.1975, 288 (2-3), 109-121.

Travis J A Craddock; Marc St George; Holly Freedman; Khaled H Barakat; Sambasivarao Damaraju; Stuart Hameroff; Jack A Tuszynski. Computational predictions of volatile anesthetic interactions with the microtubule cytoskeleton: implications for side effects of general anesthesia.PLoS ONE.2012, 7 (6), e37251.

GHS Gefahren- und Sicherheitshinweise

Gefahrenhinweise (EU): H318-H341

Causes serious eye damage. Suspected of causing genetic defects.

Sicherheitshinweise: P201-P280-P281-P202-P305+P351+P338-P310-P308+P313-P405-P501a

Obtain special instructions before use. Wear protective gloves/protective clothing/eye protection/face protection. Use personal protective equipment as required. Do not handle until all safety precautions have been read and understood. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER or doctor/physician. IF exposed or concerned: Get medical advice/attention. Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.

Weitere Referenzen

Merck
14,4603
Beilstein
1736947
Harmonized Tariff Code
2903.79
TSCA
No
RTECS
KH6550000

Empfohlen

  • A10221

    Imidazole, 99%
  • L16725

    2-Chloro-1,1,2-trifluoroethyl difluoromethyl ether, 97%
  • L16891

    Fluoromethyl 1,1,1,3,3,3-hexafluoroisopropyl ether, 98+%
  • L17285

    2,2-Dichloro-1,1-difluoroethyl methyl ether, 97%
  • L17315

    1-Chloro-2,2,2-trifluoroethyl difluoromethyl ether, 97%

Kürzlich angesehen

Chemikalien

Life science

Metalle und Stoffe

Katalysatoren

Forschungs- und Laborbedarf